Safety Summary of Pediatric Inflammatory Bowel Disease Therapies
Authors:
- 7 June 2023
- journal article
- research article
- Published by Elsevier in Gastroenterology Clinics of North America
- Vol. 52 (3) , 535-548
Abstract
No abstract availableKeywords
Funding Information
- Janssen Pharmaceutica
This publication has 92 references indexed in Scilit:
- Pediatric and Adolescent Tuberculosis in the United States, 2008–2010Pediatrics, 2012
- Near Elimination of Varicella Deaths in the US After Implementation of the Vaccination ProgramPediatrics, 2011
- Autoimmune-like syndromes during TNF blockade: does infection have a role?Nature Reviews Rheumatology, 2011
- A Systematic Review of Factors That Contribute to Hepatosplenic T-Cell Lymphoma in Patients With Inflammatory Bowel DiseaseClinical Gastroenterology and Hepatology, 2011
- Once-Daily Dosing of Delayed-Release Oral Mesalamine (400-mg Tablet) Is as Effective as Twice-Daily Dosing for Maintenance of Remission of Ulcerative ColitisGastroenterology, 2010
- Definition of Phenotypic Characteristics of Childhood-Onset Inflammatory Bowel DiseaseGastroenterology, 2008
- Preoperative Steroid-Related Complications in Japanese Pediatric Patients With Ulcerative ColitisDiseases of the Colon & Rectum, 2006
- Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor AntagonistsClinical Infectious Diseases, 2004
- Diarrhea Associated with Mesalamine in a Patient with Chronic Nongranulomatous EnterocolitisNew England Journal of Medicine, 1998
- Inhibition of Folate Enzymes by SulfasalazineJournal of Clinical Investigation, 1978